Ipswich Investment Management Co., Inc. Biogen Inc. Transaction History

Ipswich Investment Management Co., Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 09, 2020	SELL	$258.66 - $342.55 $201,754 - $267,189	-780 Closed	0 $0
Q1 2020 Apr 09, 2020	SELL	$268.85 - $341.04 $6,721 - $8,526	-25 Reduced 3.11%	780 $247,000
Q4 2019 Jan 08, 2020	SELL	$220.06 - $304.07 $47,312 - $65,375	-215 Reduced 21.08%	805 $239,000
Q3 2019 Oct 08, 2019	SELL	$217.44 - $243.88 $800,179 - $897,478	-3,680 Reduced 78.3%	1,020 $237,000
Q2 2019 Jul 11, 2019	SELL	$219.29 - $241.72 $484,411 - $533,959	-2,209 Reduced 31.97%	4,700 $1.1 Million
Q1 2019 Apr 12, 2019	BUY	$216.71 - $338.96 $123,524 - $193,207	570 Added 8.99%	6,909 $1.63 Million
Q4 2018 Jan 15, 2019	SELL	$278.5 - $352.75 $1,671 - $2,116	-6 Reduced 0.09%	6,339 $1.91 Million
Q3 2018 Oct 09, 2018	BUY	$293.51 - $383.83 $1.86 Million - $2.44 Million	6,345 New	6,345 $2.24 Million
Q2 2018 Jul 18, 2018	SELL	$257.52 - $306.91 $1.53 Million - $1.83 Million	-5,951 Closed	0 $0
Q1 2018 Apr 12, 2018	BUY	$260.13 - $367.91 $3,901 - $5,518	15 Added 0.25%	5,951 $1.63 Million
Q4 2017 Jan 16, 2018	BUY	$307.64 - $344.58 $106,443 - $119,224	346 Added 6.19%	5,936 $1.89 Million
Q3 2017 Oct 11, 2017	BUY	$281.15 - $329.69 $1.57 Million - $1.84 Million	5,590	5,590 $1.75 Million

1,015

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Ipswich Investment Management Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Ipswich Investment Management Co., Inc. with notifications on news.